As GLP-1 medicine reshape the weight-loss market, Signos provides a glucose monitoring system as a device that may work alongside GLP-1 medicines or stand alone as a drug-free possibility
Signos has obtained clearance from the U.S. Meals and Drug Administration for what it says is the primary over-the-counter glucose monitoring system designed for weight administration, giving the Silicon Valley startup a regulatory edge within the booming metabolic well being market.
The Palo Alto-based firm packages an AI-powered platform with Dexcom’s Stelo steady glucose sensor, permitting customers to trace how meals, exercise, stress and even sleep have an effect on their glucose ranges in real-time. Signos says members report shedding as much as 7.75% of their beginning weight inside six months.
“That is greater than a product launch — it’s a mission,” Signos founder and CEO Sharam Fouladgar-Mercer stated. “Everybody deserves entry to insights that assist them stay more healthy, longer, extra vibrant lives. Signos isn’t nearly knowledge; it’s about giving individuals possession over their well being and weight journeys in a means by no means earlier than seen.”
The clearance follows a $20 million Series B funding round in 2023, led by Cheyenne Ventures and Google Ventures with assist from Dexcom Ventures and Samsung Subsequent. On the time, Signos stated the capital would broaden its staff and fund extra metabolic well being analysis.
Signos says its platform interprets glucose fluctuations and interprets them into personalised, AI-driven suggestions that may information on a regular basis selections on meals, train and restoration. Signos provides two HSA/FSA-eligible subscription plans: a three-month possibility at $139 a month, which incorporates six CGM sensors and 6 adhesive patches shipped collectively, and a six-month plan at $129 a month, which incorporates 12 sensors and patches delivered in two shipments. Each present two CGMs monthly shipped quarterly.
“I’ve been utilizing Signos for years now, and regardless of my psychological ups and downs, it’s there to maintain me in actuality,” actress and Signos advisor Raven-Symoné stated. “The truth is issues change, ranges change, however if you happen to control the general image, you possibly can maintain your well being within the inexperienced. Signos provides me the boldness to take pleasure in life whereas being conscious of my physique and what it wants.”
Signos additionally provides diet assist by a partnership with Nourish, a telehealth platform that recently raised $70 million in a Collection B spherical and connects customers with registered dietitians. Based on the corporate, 93% of members pay nothing out of pocket, whereas those that do incur prices obtain a locked-in, cheaper price organized by Signos, based on its web site.
At the same time as new instruments emerge in pharma and well being tech, from GLP-1 weight reduction medicine to digital monitoring platforms, almost 74% of U.S. adults are chubby or overweight, based on the Facilities for Illness Management and Prevention and 88% are thought-about metabolically unhealthy. International diabetes diagnoses are projected to succeed in 1.3 billion by 2050, most of them sort 2 circumstances, the World Well being Group estimates.
